Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Buter

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
European Journal of Cancer (Oxford, England : 1990)|September 30, 2008
Phase II study on gemcitabine in recurrent and/or metastatic adenoid cystic carcinoma of the head and neck (EORTC 24982)C M L van Herpen, L D Locati, J Buter, et al.
Oral Oncology|February 7, 2020
The course of symptoms of anxiety and depression from time of diagnosis up to 2 years follow-up in head and neck cancer patients treated with primary (chemo)radiationF E van Beek, F Jansen, L Mak, et al.
Journal of Dairy Science|April 7, 2023
Prevalence of extended-spectrum and AmpC β-lactamase-producing Escherichia coli in young calves on Dutch dairy farmsM A Gonggrijp, A G J Velthuis, A E Heuvelink, et al.
European Journal of Cancer (Oxford, England : 1990)|May 9, 2003
Extended neoadjuvant chemotherapy in locally advanced breast cancer combined with GM-CSF: effect on tumour-draining lymph node dendritic cellsH M Pinedo, J Buter, S A Luykx-de Bakker, et al.
Oral Oncology|August 13, 2018
The course of sexual interest and enjoyment in head and neck cancer patients treated with primary (chemo)radiotherapyH C Melissant, F Jansen, L E R Schutte, et al.
Journal of Neuro-Oncology|July 13, 2016
Prognostic value of the S100B protein in newly diagnosed and recurrent glioma patients: a serial analysisF K Holla, T J Postma, M A Blankenstein, et al.
Journal of Neuro-Oncology|November 23, 2013
Central neurotoxicity of standard treatment in patients with newly-diagnosed high-grade glioma: a prospective longitudinal studyF E Froklage, L J Oosterbaan, E M Sizoo, et al.
British Journal of Cancer|June 2, 2011
Phase I dose-escalation study to determine the safety, pharmacokinetics and pharmacodynamics of brivanib alaninate in combination with full-dose cetuximab in patients with advanced gastrointestinal malignancies who have failed prior therapyC R Garrett, L L Siu, A El-Khoueiry, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
European Journal of Cancer (Oxford, England : 1990)|September 30, 2008
Phase II study on gemcitabine in recurrent and/or metastatic adenoid cystic carcinoma of the head and neck (EORTC 24982)C M L van Herpen, L D Locati, J Buter, et al.
Oral Oncology|February 7, 2020
The course of symptoms of anxiety and depression from time of diagnosis up to 2 years follow-up in head and neck cancer patients treated with primary (chemo)radiationF E van Beek, F Jansen, L Mak, et al.
Journal of Dairy Science|April 7, 2023
Prevalence of extended-spectrum and AmpC β-lactamase-producing Escherichia coli in young calves on Dutch dairy farmsM A Gonggrijp, A G J Velthuis, A E Heuvelink, et al.
European Journal of Cancer (Oxford, England : 1990)|May 9, 2003
Extended neoadjuvant chemotherapy in locally advanced breast cancer combined with GM-CSF: effect on tumour-draining lymph node dendritic cellsH M Pinedo, J Buter, S A Luykx-de Bakker, et al.
Oral Oncology|August 13, 2018
The course of sexual interest and enjoyment in head and neck cancer patients treated with primary (chemo)radiotherapyH C Melissant, F Jansen, L E R Schutte, et al.
Journal of Neuro-Oncology|July 13, 2016
Prognostic value of the S100B protein in newly diagnosed and recurrent glioma patients: a serial analysisF K Holla, T J Postma, M A Blankenstein, et al.
Journal of Neuro-Oncology|November 23, 2013
Central neurotoxicity of standard treatment in patients with newly-diagnosed high-grade glioma: a prospective longitudinal studyF E Froklage, L J Oosterbaan, E M Sizoo, et al.
British Journal of Cancer|June 2, 2011
Phase I dose-escalation study to determine the safety, pharmacokinetics and pharmacodynamics of brivanib alaninate in combination with full-dose cetuximab in patients with advanced gastrointestinal malignancies who have failed prior therapyC R Garrett, L L Siu, A El-Khoueiry, et al.
Pageof 5